CCNA2 and hepatocellular carcinoma: A previous study reported that the upregulation of cyclin A2 enhanced the migration of hepatocellular carcinoma (HCC), while its downregulation decreased the migration of DLD‐1 and SW620 colorectal cancer cell lines (CRC) [38, 43].